Clinical trials
Phase 1 Thrombocytopenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 3 |
| Withdrawn | 3 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 5 |
| Anhui Provincial Hospital | 2 |
| National Cancer Institute (NCI) | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Anjali Sharathkumar | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Cellphire Therapeutics, Inc. | 1 |
| Children's Oncology Group | 1 |
| Chongqing Peg-Bio Biopharm Co., Ltd. | 1 |
| City of Hope Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocytopenia | 32 |
| Anemia | 5 |
| Myelodysplastic Syndromes | 4 |
| Hemorrhage | 3 |
| Neoplasms | 3 |
| Neutropenia | 3 |
| Purpura | 3 |
| Anemia, Aplastic | 2 |
| Autoimmune Diseases | 2 |
| Hematologic Diseases | 2 |
Trials
Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.